The announcement of a mixed shelf offering typically leads to concerns about dilution among existing shareholders, which can cause a short-term decrease in stock price. Given the size of the offering relative to Jaguar Health's market cap, this news is highly relevant and important to JAGX investors, hence the negative impact on the stock price.